Professor Beverley Hunt OBE
Founder of Thrombosis UK and Professor of Haemostasis & Thrombosis, Guy's & St Thomas's Hospital, London.
Professor Beverley Hunt OBE is Professor of thrombosis and haemostasis at King's College and Guy's & St Thomas's, London and is a consultant in the departments of haematology & pathology. She is a national and international expert in thrombosis and acquired bleeding disorders.
She has sat on multiple national and international guideline writing groups, including NICE has extensive clinical experience of thrombotic and acquired bleeding disorders and runs a very active research group with over 400 peer-reviewed publications to her name.
Prof Hunt is chair of the steering committee of World Thrombosis Day.
Professor Simon Noble
Medical Director of Thrombosis UK and Marie Curie Professor of Supportive & Palliative Medicine in Cardiff University and honorary consultant Royal Gwent Hospital Newport.
Dr Noble's main research interests are in the management of venous thromboembolism in advanced cancer, the anticancer effects of heparins and the quality of life associated with VTE. He set up the South East Wales Cancer Associated Thrombosis Service which sees 500 new cases per year.
He is chief investigator on the International PELICAN study which explored the impact of cancer associated thrombosis (CAT) on patients in different countries and healthcare settings.
He has sat on several clinical guideline groups including NICE CG89, ASH CAT guidelines and several ISTH guidance documents. He is Medical Director of Thrombosis UK and medical advisor to Anticoagulation UK. He has published over one hundred original papers, twenty seven chapters and six books. His interests include hill walking, travel and hip-hop.
Huw Rowswell Consultant Nurse thrombosis, University Hospitals Plymouth NHS Trust
Vice Chair Clinical Leaders of Thrombosis and Trustee British Society of Haematology
Huw trained in London at St Marys Paddington and initially worked in respiratory medicine before moving to critical care then helping set up the acute care team in Plymouth. He joined the Plymouth thrombosis team in 2009 when it became an exemplar centre.
He became a nurse consultant in 2016 with responsibility for investigating hospital acquired VTE giving real time feedback to clinicians. He completed his MSc with a dissertation on VTE in cardiac surgery comparing emergency with elective patients and has published many articles on VTE outcome data. He is the UK representative for the “All China nursing VTE alliance” and was appointed the hospital VTE lead and chair of the thrombosis committee in 2020.
Dr Karen Breen is an experienced and renowned consultant haematologist at Guy’s and St Thomas’s hospital, London. Her specialties include thrombosis, obstetric haematology, and clotting, bleeding, and platelet disorders.
Dr Breen completed her basic medical training whilst in Ireland, achieving her MB BCh in 2000. She later received her membership with the Royal College of Physicians of Ireland before eventually receiving her fellowship with the Royal College of Pathology. Dr Breen received her postgraduate haematology speciality training mostly in Ireland. She later relocated to London to complete research on antiphospholipid syndrome which led to her receiving an MD in 2015.
Dr Breen has maintained a strong interest in her research. She continues to conduct research on antiphospholipid syndrome and thrombosis. Presently, she is involved in several current clinical trials and translational research. Dr Breen has had her work published in various peer-reviewed journals. On a regular basis, Dr Breen lectures both nationally and internationally.
Paul Bennett is a clinical and academic psychologist, who has worked in both NHS and universities in Bristol, Cardiff and Swansea. He has previously published research on the psychological impact of VTE and is presently an emeritus professor of psychology at the University of Swansea and a clinical psychologist providing support for vaccine induced thrombocytopenia and thrombosis (VITT) patients through the auspices of Thrombosis UK.
Dr Raza Alikhan
Consultant Haematologist, Haemophilia and Thrombosis Centre, University Hospital of Wales, Cardiff
Dr Raza Alikhan is a consultant haematologist at the Haemophilia and Thrombosis Centre, University Hospital of Wales and member of the British Society for Haematology (BSH) Thrombosis and Haemostasis Task Force and Guideline Committee and Chair of the BSH Cancer Associated Thrombosis Guideline Writing Group. He is a Fellow of the Royal College of Pathologists and a Member of the Royal College of Physicians having received his medical degree from the University of London and completed postgraduate studies in London and Oxford. He defended his doctoral thesis on venous thromboembolism and prophylaxis in medical patients and was the UK National Lead Investigator for the rivaroxaban medical thromboprophylaxis study (MARINER). He is he UK Chief Investigator for both the apixaban treatment of cancer associated thrombosis study (CARAVAGGIO) and the apixaban length of stay pulmonary embolism study (ALPHA-PE).
Dr Alikhan has been involved in phase II–IV anticoagulant clinical trials since the late 90s. His current research interests include the identification of risk factors and outcomes associated with anticoagulation related bleeding. He is the UK Chief Investigator for the andexanet alfa DOAC and LMWH antidote study (ANNEXA-4) and is a member of the steering committee for the oral anticoagulant agent associated bleeding events reporting system (ORANGE) and the secure anonymised information linkage bleeding risk evaluation (SABRE) study. He has authored more than 100 conference abstracts, peer-reviewed papers and book chapters on thrombosis and haemostasis.
Dr Narayan Karunanithy MRCS FRCR FCIRSE
Dr Karunanithy is Consultant Interventional Radiologist and Honorary Senior Lecturer at Guy’s & St Thomas’ NHS Foundation Trust, London. He graduated with honours from Guy’s, King’s and St Thomas’ Medical School.
His subspecialty interests are Venous/PE, renal dialysis/transplant intervention and non-invasive MR/CT imaging .
He is the site Principal Investigator for the HI-PEITHO and OPTALYSE-PE trials evaluating the role of catheter directed therapy in acute pulmonary emboli (Clinicaltrials.gov NCT02396758) and Deputy CI for the NIHR funded multicenter randomized controlled trial studying the benefit of drug eluting balloon angioplasty is dysfunctional AV access (PAVE, http://www.nets.nihr.ac.uk/projects/eme/139410). He has served as site PI for the completed VIVO-EU registry evaluating the Cook Zilver Vena venous stent (ClinicalTrials.gov NCT01663051) and Lutonix Global SFA Registry (ClinicalTrials.gov NCT01864278).
He has authored over 30 publications and book chapters (www.researchgate.net/profile/Narayan_Karunanithy/). He serves as expert faculty at many national and international conferences.
Vicki qualified as a pharmacist in 2005 (University of Nottingham) and joined Guy’s and St Thomas’ NHS Foundation Trust as a resident pharmacist in 2006 and has worked in various clinical pharmacist roles, including 5 years as a senior cardiovascular pharmacist. She has a post-graduate diploma in General Pharmacy Practice (University College London) and has been a practicing independent pharmacist prescriber since 2014 (King’s College London) and completed a physical assessment skills module (St George’s).
Vicki has been Consultant Pharmacist for Haemostasis & Thrombosis since August 2017 working within the Trust monitoring and developing anticoagulation services, and working to improve referral pathways and access for patients in South London. She has regular outpatient clinics for initiating and monitoring anticoagulation as well as the weekly rapid access AF clinic. She is a UKCPA Haemostasis and Thrombosis committee member since 2019.
Sarah Whittley
Sarah Whittley is a Clinical Trial Manager within the Department of Surgery and Cancer at Imperial College London. Sarah has research experience in both academic and commercial clinical trials. She has worked in various therapeutic areas such as vascular surgery and COVID-19 vaccinations. Sarah currently manages the NIHR funded multicentre cluster randomised controlled trial “examining the benefit of graduated compression stockings in the Prevention of vEnous Thromboembolism in low-risk Surgical patients (the PETS trial).”
Hannah Eden
My name is Hannah Eden and I'm 22 years old. I currently live in West Yorkshire. After having a DVT at the age of 18, I have developed a keen interest in research around VTE and how we can improve patient's experiences in their diagnosis and lifelong treatment. I'm also interested in the psychological, long term impact of VTE and how we can work together to make health professionals aware of this.
Dr Gillian Lowe
Consultant Haematologist specialising in Haemostasis and Thrombosis and has a specialist interest in problems with bleeding and thrombosis.
Dr Lowe trained in Cambridge, Manchester and Birmingham.
Dr Matthew Fay
GP Principal, Willows Medical Practice, Bradford
Dr Matthew Fay is a General Practitioner who joined Westcliffe Medical Practice in 1999. This has developed into the Affinity Care, a 27 partner “superpractice” based in Bradford managing 8 GP contracts and providing care for over 64,000 population.
Matthew is the Clinical Chair of the partnership and the clinical director of Affinity Care PCN, but still does regular GP sessions at The Willows in Queensbury. In 2001 Matthew established a GPwSI cardiology service in Bradford which has expanded to provide direct access investigations and e-consultations.
He was a member of the NICE AF Guideline Development Group and was a standing committee member of the NICE Quality Standard Advisory Committee. He is currently a clinical advisor to the AF Association, STARS (the Syncope Trust), Arrhythmia Alliance, on the Expert Advisory Panel for the Stroke Association and on the faculty for Heart Valve Voice. He is a Trustee of the AF Association and Thrombosis UK. He has been involved in service redesign of cardiovascular services with a focus on AF, dysrhythmia and moving services out of hospital for many years. He was the clinical lead of the redesign of the Bradford VTE services to make it completely community and NOAC based.
He has previously worked in Bradford’s PCTs and CCG. In 2022, after over 20 years in general practice he took the decision to take on new challenges and was appointed as the medical director of LumiraDx. He still has an active interest in the Westcliffe Health Innovations cardiovascular service and through these roles continues to look for ways to enhance the patient journey from symptoms, to diagnosis, to support in the post diagnosis phase of their lives.
Dr Daniel Horner
Dr Dan Horner, Consultant in Emergency and Critical Care Medicine; Northern Care Alliance NHS Foundation Trust
Dan Horner is a consultant in emergency medicine/intensive care at a major trauma and neurosciences centre in the North West of England. He is the outgoing Professor of the Royal College of Emergency Medicine and has research interests in the prevention and treatment of venous thromboembolic disease, trauma coagulopathy and early sepsis management.
Dan is a topic expert for several NICE guidelines, including NG158 on VTE diagnosis and management, and the accompanying quality standards. Dan also chairs the thrombosis committee at his local hospital, which is an accredited national exemplar centre for VTE care. He occasionally blogs (stemlynsblog.org) and infrequently tweets (@exRCEMProf).
https://www.research.manchester.ac.uk/portal/daniel.horner.html
Qualified as State Enrolled Nurse in 1983 at West Middlesex Hospital. Jackie then worked as Enrolled Nurse in Surgical ward until 1996.
Following this Jackie moved to Wound Care unit in 1996.Jackie undertook a Diploma in Nursing at Buckingham and Chilterns University in 1998 from which she qualified as Registered General Nurse.
This soon led to Jackie being promoted to Senior Staff Nurse in wound care and a year later, promoted to Sister in charge of the Wound Care Unit.
In 2000 she moved into a management role as Senior Nurse Manager of a busy outpatients’ department in West Middlesex University Hospital.
In 2004 Jackie started working part-time in the Anticoagulation Department at St Peters Hospital moving to a full-time role as Anticoagulation Nurse Specialist where she continues to work today.
I completed my nurse training at King's College Hospital in 2010.
I have worked as a clinical nurse specialist (junior- senior) in thrombosis and haemostasis since 2014.
I Completed an MSc in Advanced Practice and have conducted research looking at how clinical nurse specialists transition into this role.
Catherine Nelson-Piercy is a Professor of obstetric medicine and consultant obstetric physician.
She specialises in the care of women with medical problems in pregnancy. She offers pre-pregnancy counselling for women with pre-existing medical problems and those with problems in previous pregnancies. Catherine runs special joint clinics for women with renal disease, cardiac and rheumatic disorders, hypertension and epilepsy in pregnancy.
She is the immediate past president of the International Society of Obstetric Medicine, editor in chief of the journal 'Obstetric Medicine: the medicine of pregnancy' and has over 200 publications. She has been one of the central assessors for the confidential enquiry into maternal deaths in the UK since 2005 and is a trustee for the charity APEC- Action on Pre-eclampsia.
Professor Cheng-Hock Toh CBE is Professor and Consultant in Haematology at Liverpool. He is Chair of the National Blood Transfusion Committee and has been President of the British Society for Haematology and Academic vice-president of the Royal College of Physicians. His longstanding research interest has been on blood changes in patients with sepsis and critical illness. The impact of this work includes discovering new molecular mechanisms of thrombin generation during critical illness, which have led to spin-out business companies for point-of-care diagnostics.
Prof Nicola Mutch currently holds a personal Chair at the University of Aberdeen. Nicola Studied for a PhD at the University of Aberdeen in the field of thrombosis and vascular biology. Having performed her post-doctoral studies at the University of Illinois in the laboratory of Prof James Morrissey. Nicola transitioned back to the UK to take up a Tenue-Track Independent Research Fellowship within cardiovascular medicine at the University of Leeds.
She was subsequently awarded a British Heart Foundation Fellowship and returned to the University of Aberdeen. In 2017 Nicola was promoted to Reader and was awarded a Personal Chair in December 2021. Her laboratory aims to understand the molecular and cellular mechanisms underpinning haemostasis and how these are perturbed in pathophysiological situations, such as myocardial infarction, stroke, deep vein thrombosis and haemorrhagic conditions.
Dr. Suthesh Sivapalaratnam, MD PhD MRCP (London) FRCPath
Dr Suthesh Sivapalaratnam studied Medicine at the University of Amsterdam. He was awarded a PhD fellowship by the Academic Medical Centre in Amsterdam and did his research between the University of Cambridge (Supervisor: Prof. W. H. Ouwehand) and the University of Amsterdam (Supervisor: Prof. M. Levi). In 2012 he defended his thesis on “The Molecular Basis of Early onset Cardiovascular Disease”. He received his core medical training at the Academic Medical Center in Amsterdam. During this period, he also completed a 12-month stint as a Post-doctoral Fellow at the Center for Human Genetic Research at the Massachusetts General Hospital Boston and the Broad Institute, Boston (USA). In 2015 he rejoined the Ouwehand Group, where he continued his research and focused on the genetic basis of rare inherited Bleeding and Platelet Disorders. In 2015 he secured one of the highly prestigious TRTH fellowships of the American Society of Haematology/European Haematology Association.
His current clinical practice spans paediatric and adult Haemostasis and Thrombosis (HT). He works at one of the largest haemophilia practices in the world, that encompasses 1800 patients with rare bleeding disorders. He leads the paediatric HT service, is the genomics lead and MDT chair for North London and interim academic lead for clinical haematology.
He is the Chief Medical Officer and part of the day to day management team of BloodCounts! which was awarded £1 million by the Trinity Challenge. He has been an active participant in several consortia, including Bloodomics, Cardiogenics and the Bleeding, and the Platelet Disorder Cohort for the NIHR. He is currently a PI on 4 clinical trials in Haemophilia, Thrombosis and sub-PI for Gene Therapy for Haemophilia and Gene editing in Sickle Cell. He is the co-supervisor for 4 PhD students and also supervises one clinical fellow in young thrombosis research. He co-leads the HaemAI group which spans 6 team members. His leadership and collaborative skills are further demonstrated in his clinical roles, the 70+ peer reviewed papers he has published, Google Scholar h-index 30, and numerous committees including the organising committee for the ISTH 2022 (attendees ~ 4500) conference.
My name is Andrew Morris, I am 37 years of age, I survived a provoked VTE in March 2018, three months after being hit by a car. I was a very active person, but due to the delay in diagnosis this has had a major impact on my life. My wife was told 3 times in one week, that I was not going to pull through. Fortunately I did! However, this has been life changing and will be something that I now have to live with for the rest of my life.
Despite attending emergency rooms and GP practices with symptoms, my DVT failed to be diagnosed on several occasions until a nurse from the local minor injuries unit thought about thrombosis and saved my life!
Since then, I have been trying to raise awareness around VTE’s. I have also been involved in trials with Guys and St Thomas’ Trust, and campaigns to raise this awareness.
I am passionate about helping, so all practitioners can learn from these errors.
Helen Williams FFRPS, FRPharmS
Consultant Pharmacist for Cardiovascular Disease, South East London CCG and UCLPartners
National Specialty Adviser for CVD Prevention, NHSE and I
Email: helen.williams11@nhs.net
Helen is the National Speciality Adviser for CVD Prevention at NHS England and is working on delivery of the national CVD ambitions for AF, Blood Pressure and Cholesterol in the NHS Long Term Plan. Helen has worked as a CVD specialist for more than 25 years across all care settings. She was clinical adviser to the national AF programme and developed the pharmacist-led virtual clinic model to optimise uptake of anticoagulation in AF, which has now been spread nationally. Helen has recently been appointed as one of the long term conditions lead for South East London Integrated Care System and is also working at UCLPartners on the implementation of proactive care frameworks for long-term conditions to support primary care in the post COVID-19 environment.
Becs Walsh, Lead Pharmacist for Anticoagulation & Thrombosis Prevention, Sheffield Teaching Hospital NHS Foundation Trust.
Becs graduated from Bradford University with a Masters degree in Pharmacy in 2002 and undertook pre-registration pharmacy training in Sheffield, qualifying in 2003. She completed a post-graduate diploma in Clinical Pharmacy in 2005 completing rotations through various medical and surgical specialties. She worked in oncology and palliative care before becoming the first pharmacist to be employed in the role of thrombosis prevention & anticoagulation at Sheffield in 2009. Becs is an active member of the Yorkshire & Humber Anticoagulation Pharmacists group and professional secretary of the local thrombosis committee.
Rosalind Byrne is lead pharmacist for Anticoagulation at King’s College Hospital NHS Foundation Trust in London. She has been in post since 2008. She runs an outpatient clinic initiating and reviewing patients on anticoagulation with the direct oral anticoagulants and warfarin. She was part of a team who conducted an anticoagulation in AF project in South London which has now been rolled out nationally by NHSE. She is also involved in the wider management of patients on anticoagulation in conjunction with local CCGs and colleagues at local acute trusts. She is currently undertaking an MSc in Pharmacy Practice specifically conducting a project to compare the efficacy of warfarin and DOACs in the treatment of LV thrombus.
Stephane qualified as a Doctor of Pharmacy in 1994 in Nantes (France) and moved to the UK in 1998 where he worked as a community pharmacist for 14 years. He transferred to the secondary care sector in 2009 as clinical pharmacist within a treatment centre providing elective procedures in major orthopaedic surgery, general surgery, gynaecology, ENT and ophthalmology specialties.
Stephane developed a particular interest in anticoagulation, especially postoperative Venous Thrombosis prevention and perioperative management of anti-thrombotic drugs. He created a thrombosis committee for the hospital of which he is the lead and is now heavily involved in the development of national policies for VTE prophylaxis and perioperative use of anti-thrombotic medicines.
Katherine Stirling is a consultant pharmacist for anticoagulation and thrombosis at Leeds Teaching Hospitals. She has been in post since 2011. Since 2019 she has also been working for 1 day a week with Leeds CCG GP confed team on the NHSE AF project.
Her role covers all areas of thrombosis and anticoagulation including VTE prevention. She is a member of the trusts thrombosis steering group and regularly attends VTE MDT meetings. Her clinical role involves out-patient anticoagulant clinics for patients on oral and injectable anticoagulants. He is a supervisor for a PhD student looking at the barriers and enablers to the uptake of DOACs and has a research interest in the use of DOACs at extremes of weight.
Dr Moore studied medicine in Edinburgh before moving to Gloucestershire to work as a GP principal. He has an interest in cardiology and cardiovascular disease, particularly those aspects that are relevant to Primary Care and contributes regularly to related educational events across the UK. He is President of the Primary Care Cardiovascular Society.
Dr Moore was involved in the development of the Primary Care based Gloucestershire Heart Failure service where he continues to work as a GPwSI.
He continues to represent Primary Care in the cardiovascular arena at both a local and national level. He has provided cardiovascular clinical support to local commissioning organisations for over ten years and remains actively involved in commissioning local cardiology services chairing the Circulatory Clinical Programme Group for Gloucestershire Clinical Commissioning Group (CCG). He was Clinical Lead for the community based West of England AHSN Stroke Prevention in AF project -“Don’t wait to anticoagulate”.
Dr Moore previously served on the board of the British Society for Heart Failure and was a member of the NICE Chronic Heart Failure Guideline committee (2018). He currently sits on the National Heart Failure Audit Steering group.
Dr Will Lester, MBChB (hons), BSc, FRCP, FRCPath, PhD
Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK
Dr Will Lester is a Haematology Consultant at University Hospitals Birmingham and provides clinical and laboratory haematology services at the Birmingham Women’s Hospital. He is also an Honorary Senior Clinical Lecturer at the University of Birmingham. Dr Lester’s clinical and research interests include thrombosis, haemostasis, obstetric and immunohaematology.
He is vice chair of the Haemostasis and Thrombosis task force for the British Society of Haematology guidelines committee, secretary for the NEQAS blood coagulation steering committee and is co-chair of the UKHCDO laboratory working party.
Consultant Stroke Physician
Since his appointment as Consultant Stroke Physician in 2008, Dr Indira Natarajan has held various leadership positions within stroke care, both regionally and nationally. Dr Indira has always been a champion and ambassador for stroke victims, with roles in Midlands Stroke Clinical Network and University Hospital of North Midlands NHS Trust. He has raised the profile of services in all aspects of care from Stroke prevention to end of life support for stroke patients in the community, and is widely known for all his innovative work.
Dr Indira has pioneered innovations in the area of interface, working for stroke prevention in patients with arterial fibrillation (AF) and the introduction of Sky Medical Technology’s geko device as an adjunct to current VTE prevention guidelines which has benefited a lot of stroke patients. Dr Indira has been played a key role in winning several awards for innovation in stroke practice, including Health and Social Awards for Stroke Services and the Health Care Pioneers award showcasing Best Practice in AF presented by the Atrial Fibrillation Academy.
Alexander (Ander) Cohen MB BS (hons), MSc, MD, FRACP, FESC
Department of Haematological Medicine, Guy’s and St Thomas’ Hospital, King’s College London, United Kingdom
Alexander Cohen is a vascular physician and epidemiologist at Guy’s and St Thomas’ Hospital, King’s College, London, UK.
Dr Cohen graduated with honours in Medicine and honours in Surgery from the University of Melbourne, Australia, and became a fellow of the Royal Australasian College of Physicians in 1990. He was awarded an MSc in epidemiology from the London School of Hygiene and Tropical Medicine, University of London, in 1991 with a thesis on the metabolic syndrome in South Asian populations. In 1998, he was awarded an MD with a thesis on the epidemiology of venous thromboembolism and thromboprophylaxis. He is a Fellow of the European Society of Cardiology.
In addition to his clinical, supervising and teaching work, Dr Cohen is involved in designing, managing and analysing clinical trials. He is the Chairman and a member of many international trial steering committees, epidemiological and pharmacoeconomic studies.
Dr Cohen has written and co-authored over 500 publications and is on the editorial board of several journals. He has over 40 publications in The Lancet and New England Journal of Medicine, as well as over 20 in the BMJ, Blood, Circulation, Annals of Internal Medicine and JAMA Internal Medicine.
Dr Choudhuri is a Consultant Haematologist at Pennine Acute NHS Trust and Honorary Senior Lecturer at Manchester Metropolitan University. She completed her basic and specialist Haematology training in Manchester. Her main interest is in venous thromboembolic disorders and anticoagulation and myeloma and plasma cell dyscrasias. She is the Cancer Lead for the department and is involved in collaborative projects focused on improving cancer service delivery. She is also a member of the Myeloma guidelines development group of BSH, and is currently co-authoring the national guidelines for Relapsed Myeloma. Dr Choudhuri is the Education Lead for British Society of Haematology, North West England and Wales and Chairperson for North West Haematology Association. She is extensively involved in organising, conducting and chairing regular meetings of specialist education groups and clinical trial committees. She has recently won the prestigious national HSJ award for improving care in older people initiative of the year.
Sarah Havord, VTE Prevention Specialist Nurse, Oxford University Hospitals NHS Foundation Trust
Sarah started her Adult Nursing training in 2011 and graduated from Oxford Brookes University in 2014 with a Hons Degree in Adult Nursing. In 2013 she worked in a surgical specialty including colorectal, gynaecology and breast cancer before joining the VTE Prevention Service. She has recently submitted her dissertation on the emotions experienced by those with a cancer associated VTE and graduating next year with a Nursing Masters. Sarah has a passion in innovation, sustainability, and teaching with an active role in engaging and supporting others within the thrombosis network.
My Name is Tinaa Simmons-Lindill
My Role is Patient Safety Improvement Team Specialist in VTE
I qualified in 1991 and have worked in secondary care throughout my career. I worked at Kettering General Hospital as a VTE Nurse between 2015-2020. I then worked as an Infection Prevention & Control Nurse for almost 2 years before taking my current role in VTE at Northampton General.
Anthony qualified as a Pharmacist in 2008 from Liverpool John Moores University. He currently works as the Lead Pharmacist for anticoagulation safety at Guy’s and St Thomas’ NHS Foundation Trust.
He has worked at the Trust in this role since 2018 having previously worked in various other NHS Trusts and Private Healthcare providers. He has completed his post graduate diploma in clinical pharmacy and independent prescribing and was an honorary clinical lecturer at Queen’s University Belfast.
I am a Senior Nurse at Guy's and St Thomas' NHS Foundation Trust. I have over 8 years' experience in leadership roles within the NHS and an MSc in Leadership in Healthcare, with a specialist interest in compassionate leadership. My clinical background is mostly in acute cardiology and for the last 3 years I have been working as Matron for Haemostasis & Thrombosis and Blood Transfusion.
I trained in 1984 in Dudley and after I qualified I worked in medicine, orthopaedics, ITU and surgery in Dudley Group of Hospitals. From 1997-1998 I worked in Leominster Community Hospital and its nurse led minor injuries unit before returning to Dudley to work as an Anticoagulant and Thrombosis Clinical Nurse Specialist managing over 5000 patients on anticoagulation. In 1998 I set up one of the first services to discharge patients from hospital with deep vein thrombosis, this expanded to deliver a nurse led DVT diagnostic service.
In June 2009 I moved to the Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust as Anticoagulation and Thrombosis Consultant Nurse. Since my appointment the Trust anticoagulation service became one of the top 5 in the country on DAWN benchmarking. I again helped set up Nurse Led DVT Diagnostic service whilst helping to develop the new DAWN DVT module and am nurse lead for the Trusts VTE Prevention Programme; ensuring compliance and HAT VTE RCA’s are completed, co-writing Trusts anticoagulation and VTE guidelines.
Since 2010 I have worked in NICE on various groups including the VTE Guideline Development Group CG 144; then their first Guideline on the diagnosis and treatment of VTE, NICE VTE Quality Group, and Update Guidelines and have been an Expert Advisor for some years.
I have been invited to the House of Commons to the All Party Parliamentary Thrombosis Group and attended and presented at meetings on both VTE and Anticoagulation. I have attended many International Symposiums for thromboembolism and published a range of articles.
I am a Committee member for Anticoagulation Specialist Association and I am dismayed to realize I have been nursing for over 37 years!
Originally trained as an SEN in the Royal Air Force, following a four year break abroad Andrea returned to the UK and in 1992 undertook Project 2000. After inheriting the management of the hospital Warfarin clinic in Bridgend General Hospital in 1995 she developed an interest in Anticoagulation. Since 2002 Andrea has pioneered and championed the need to manage all hospitalised patients appropriately keeping them safe from the associated risks of developing a Hospital Acquired Thrombosis (HAT). Since 2009 Andrea has held the role of HAT Project Lead in Abertawe Bro Morgannwg University Health Board. Andrea is Wales her passion and enthusiasm for Anticoagulation have taken her as far afield as Australia. In 2015 3 hospitals in Andrea's Health Board were recognised as Thrombosis Exemplar Centres.
Dr Alice Burridge is Associate Director of Pharmacy (Medicines Assurance & Pharmacy Governance) at UHCW NHS Trust and has a wide range of hospital pharmacy experience. Her clinical area of interest is thrombosis where she works alongside haematology colleagues reviewing new thrombosis patients in clinic utilising her CEPiP qualification. She has completed a PhD in pharmacy practice and utilised this knowledge to further develop safe prescribing in electronic systems. An example of this was published in Journal of Hospital medicine: Preventing Hypoglycemia Following Treatment of Hyperkalemia in Hospitalized Patients (2019).
